Dasatinib Synthesis via Boc-Protected Thiazole Amidation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for synthesizing Dasatinib are complex and inefficient, requiring multiple steps and costly raw materials, which complicates industrial production and results in low yields and poor purity of the final product.

Innovation Solution

A simplified method involving the reaction of specific halogenated compounds with 4-(2-hydroxyethyl) piperazine derivatives, followed by hydrolysis and amidation, to produce Dasatinib, using easily available commercial materials and reducing the number of reaction steps, thereby simplifying the process and increasing yield and purity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If traditional multi-step synthesis methods are used, then Dasatinib can be produced, but the process becomes complex and time-consuming with low yield and poor purity

Engineering Contradiction:
ImprovepurityVSAvoidsynthesis process complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The synthesis process is divided into distinct modular steps: (1) formation of the thiazole-pyrimidine intermediate, (2) conversion to the formyl chloride derivative, and (3) amidation with 2-chloro-6-methylaniline. This segmentation allows each step to be optimized independently, achieving high purity (99% HPLC) while maintaining process simplicity

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent employs preliminary protection of the amino group in the thiazole ring with a Boc group before forming the amide bond. This preliminary action prevents unwanted side reactions and ensures high regioselectivity, ultimately achieving superior manufacturing precision without adding significant complexity to the overall process

Inventive Principle:
Principle #10Preliminary action

2Productivity

If traditional synthesis methods with multiple steps are used, then Dasatinib can be synthesized, but production time increases and productivity decreases

Engineering Contradiction:
Improveproduction efficiencyVSAvoidsynthesis time
Core Design Contradiction:
ProductivityVSLoss of time

Solution Approach 1:

The patent merges the formation of the thiazole-pyrimidine linkage and the subsequent formyl chloride generation into a streamlined sequence of reactions. By combining these steps and using efficient coupling reagents, the synthesis achieves high productivity with reduced total reaction time compared to traditional separate-step methods

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The synthesis process maintains continuous useful action through optimized reaction conditions where intermediates are formed and converted in sequence without significant idle time. The amidation step follows directly from formyl chloride generation, ensuring continuous productive operation and minimizing loss of time, thereby maximizing productivity

Inventive Principle:
Principle #20Continuity of useful action

3Ease of manufacture

If conventional synthesis routes are used, then Dasatinib can be produced, but raw material costs increase and economic efficiency decreases

Engineering Contradiction:
Improvemanufacturing costVSAvoidraw material consumption
Core Design Contradiction:
Ease of manufactureVSQuantity of substance

Solution Approach 1:

The patent optimizes reaction parameters including stoichiometric ratios, temperature, and catalyst loading to minimize raw material consumption. By carefully controlling these parameters, the process achieves high productivity while reducing the quantity of expensive raw materials required, thereby improving economic efficiency and ease of manufacture

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The synthesis method incorporates strategies for recovering and reusing intermediates and catalysts. By minimizing waste generation and recovering valuable materials from the reaction mixture, the process reduces overall raw material consumption and manufacturing cost, making Dasatinib production more economically efficient

Inventive Principle:
Principle #34Discarding and recovering

4Object-affected harmful factors

If traditional multi-step synthesis is used, then Dasatinib can be synthesized, but waste production increases and environmental friendliness decreases

Engineering Contradiction:
Improveenvironmental impactVSAvoidwaste generation
Core Design Contradiction:
Object-affected harmful factorsVSLoss of substance

Solution Approach 1:

The patent converts potentially harmful byproducts into useful materials or recyclable intermediates. By designing the synthesis to minimize waste generation and converting necessary byproducts into valuable resources, the process reduces environmental impact while maintaining high productivity and manufacturing efficiency

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method achieves high yields and purity of Dasatinib, up to 99.9%, with a reduced number of reaction steps, making it more suitable for industrial production and environmentally friendly by minimizing waste production.

Implementation Method 1

the compound of Formula I reacts with the compound of Formula II to yield the compound of Formula III

Methodology Applied
Scientific EffectChemical Bonding: Chemical Bonding

Implementation Method 2

followed by hydrolysis and amidation

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Implementation Method 3

followed by hydrolysis and amidation

Methodology Applied
Scientific EffectAmidation: Chemical Bonding

Data Source

PatentEP2532662B1Synthesis process of dasatinib and intermediate thereof
Publication Date: 2016.01.27 NANJING CAVENDISH BIO ENGINEERING TECHNOLOGY CO LTD
  • EP2532662B1 patent drawingFigure 1~2
  • EP2532662B1 patent drawing
  • EP2532662B1 patent drawing

AI summary

Synthesis process of dasatinib is disclosed, which includes the step of reacting the compound of formula I with that of formula II to obtain the compound of formula III. Also disclosed is the compound of formula III which is used as an intermediate for synthesizing dasatinib. The substituents of R1, R2, R3 or R4 in formulae I, II or III are defined as in the description.